Tight Glycemic Control and Insulin Administration During Parenteral Nutrition

NCT ID: NCT02035943

Last Updated: 2014-01-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-01-31

Study Completion Date

2008-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study the investigators want to comare safety and efficacy of two different metods to administrate insulin during parenteral nutrition.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this study the investigators want to compare safety and efficacy of two different metods to administrate insulin during parenteral nutrition.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critical Ill Patient Undergone Parenteral Nutrition

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Insulin separated

Seprated infusion of insulin

Group Type ACTIVE_COMPARATOR

Insulin separated

Intervention Type DIETARY_SUPPLEMENT

separate continuos infusion of insulin

Insulin added to parenteral nutrition

Insulin added to parenteral nutrition

Group Type ACTIVE_COMPARATOR

Insulin added to parenteral nutrition

Intervention Type DIETARY_SUPPLEMENT

Insulin added to parenteral nutrition

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Insulin separated

separate continuos infusion of insulin

Intervention Type DIETARY_SUPPLEMENT

Insulin added to parenteral nutrition

Insulin added to parenteral nutrition

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Critical ill patients undergone parenteral nutrition

Exclusion Criteria

* Acute cerebral injury, pregnancy
Minimum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Policlinico Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Davide Chiumello

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sergio De Chiara, MD

Role: PRINCIPAL_INVESTIGATOR

Policlinico Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Policlinico Hospital

Milan, MI, Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

127

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Insulin Balanced Infusion System
NCT01291719 ACTIVE_NOT_RECRUITING PHASE1/PHASE2
Enteral Nutrition and Glucose Homeostasis
NCT03012867 COMPLETED PHASE4